As a scientifically oriented and impactful full-service clinical research organization (CRO) that is committed to partnering with pharmaceutical, biotechnology, and medical device firms to advance their therapies throughout the entire clinical development and regulatory submission process, Veristat works each day with a focus on improving the lives of patients with rare cancers.
In 2019, Veristat has once again committed to joining the battle to beat rare cancers by participating in the Boston Cycle for Survival event. Cycle for Survival's indoor cycling events raise funds that are critical to supporting rare cancer research.
Over the past 5 years, Veristat has committed to helping those with rare cancers by raising over $100,000 and awareness for Cycle for Survival.
This year, we are raising the bar even higher, with a goal of $50,000!
Why this matters to Veristat:
50% of People with Cancer Have a Rare Cancer
When combined, about half of all patients fighting cancer are fighting a rare cancer. These are cancers we know — such as leukemia, lymphoma, thyroid, ovarian, brain, pancreatic, and all pediatric cancers — yet research is largely underfunded.
100% Goes to Lifesaving Research Led by MSK
Every dollar you give will advance innovative studies and clinical trials led by Memorial Sloan Kettering Cancer Center (MSK). Discoveries made by MSK revolutionize how cancer is diagnosed and treated, helping patients across the country and around the world.
6 Months for Fast Impact
Not only does every dollar go to research, your gift will be in the hands of doctors and researchers within six months of the events. As a donor, you will learn about the projects supported and the breakthroughs made.
How You Can Help
Donate today. Your efforts will fight cancer and make a real impact for people who have few, if any, treatment options.
Helping our clients navigate the challenges in clinical development and bringing medical innovations to market is what motivates us to work hard and make a difference every day.
Help us make a lasting impact by joining the battle against rare cancers!